TOCOPHERSOLAN
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 575.0 | 8.4 | 1 | 6 | 82.0 | 18 | 0.77 |
- CAS
- 9002964
- UNII
- O03S90U1F2
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 6 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
| Code | Date | Title | Phase | Status |
|---|---|---|---|---|
| NCT02387580 | 2015-04-01 | Bioavailability Study of Oral OZ439 Prototype Granule Formulations Administered With Piperaquine Phosphate (PQP) Tablets | Phase 1 | Not Yet Recruiting |
| NCT01958619 | 2013-10-01 | Open Label Pharmacokinetic Study of OZ439 and Piperaquine on Administration of OZ439+TPGS Granules for Oral Suspension Alone or With Either Piperaquine Phosphate Tablets or Granules for Oral Solution in Healthy Volunteers | Phase 1 | Completed |
| NCT01853475 | 2013-04-01 | Healthy Volunteer Study of the Pharmacokinetics of Oral Piperaquine With OZ439 + TPGS Formulation in the Fasted State | Phase 1 | Completed |
| NCT01463735 | 2011-11-01 | Vitamin E Supplement in Patients With Cirrhosis and Acanthocytosis | Phase 2 | Completed |
| NCT01457690 | 2011-10-01 | Study of the Absorption of Vitamin E Water-soluble Form (Pegylated) in the Familial Hypocholesterolemia With Chylomicron Retention | Phase 3 | Active, Not Recruiting |